Samsung Biologics launches S-CHOice cell line expression technology
Samsung Biologics (KRX: 207940.KS) today held an online ceremony to announce the launch of its proprietary cell line technology, S-CHOice.
2020-08-05 09:09
---
BOSAGORA donates to Chinese Red Cross for Flood Victims in Wuhan
2020-08-05 09:00
---
HealthEngine Releases Report on the Uptake of Telehealth in Australia
2020-08-05 03:06
---
.png){kind=icon}